Light Therapy for Obsessive-compulsive Disorder (OCD)

ConditionOCD
Trial statusRecruiting
Trial phaseEarly Phase 1
Trial typeInterventional
Biological sexAll
Age17-35
SponsorWashington University School of Medicine

About this trial

The goal of this clinical trial is to test whether light therapy is effective for reducing symptoms in young adults with OCD and late bedtimes (1am or later). The main question\[s\] it aims to answer are:

Does light therapy reduce OCD symptoms? Does light therapy advance the circadian clock? If there is a comparison group: Researchers will compare a higher dose of light therapy to a lower dose to see if dose amount affects symptom reduction.

Participants will asked to:

1. Wear light therapy glasses for 1 hour each morning and complete a daily light therapy log for 5 weeks 2. Track their sleep every day with a wearable monitor and an electronic sleep diary for 5 weeks 3. Complete a 1-time assessment of sensitivity to light exposure 4. Complete self-report measures of OCD 4 times/day at baseline (2 weeks), mid-treatment (1 week), and end of treatment (1 week)

Eligibility criteria

Qualifiers

Primary DSM-5 OCD diagnosis

Bedtime 0100 or later

Age 18-35

English speaking

Disqualifiers

Subjects must not be currently participating in another research study that would influence their participation in our study.

Diagnostic status

Treatment status

Night shift work or travel more than 1 time zone outside of Central Standard Time (CST) in the past month

Trial design

Treatments tested in this trial

  • Light therapy

Treatment groups

40 Participants
are divided into 2 treatment groups